Psych Vivas · General adult psychiatry — somatic symptom and related
Illness anxiety disorder — structured clinical viva
Fellowship viva on IAD in CL cardiology: nosology, CBT, CHAMP, SSRI, collaborative care, risk.
On this page & tools
Target exams
Interpretation
Reveal interpretation
This is illness anxiety disorder (care-seeking) in a medical setting, not automatically SSD (somatic load is intermittent chest tightness with disease fear dominating after negative work-up) and not automatically delusional disorder if anxiety-driven checking and seeking dominate without a broader psychotic process. Poor insight is compatible with severe IAD; treat the health-anxiety pathway.[5][4]
Cardiology clinics have high rates of significant health anxiety — this presentation is common, not rare nuisance behaviour. Avoid pejorative “heartsink” framing; it predicts staff countertransference and missed treatable anxiety.[7]
Psychological plan. Warwick–Salkovskis cycle: catastrophic cardiac misinterpretation → pulse checking and angiogram seeking → brief relief → maintained belief. Offer specialised CBT for health anxiety (exposure, response prevention for checking/reassurance, behavioural experiments). CHAMP supports adapted CBT-HA for medical outpatients as clinically effective and cost-effective.[1][4]
Pharmacotherapy. Optimise SSRI for health anxiety and depression: options with trial anchors include paroxetine (Greeven RCT) or fluoxetine (Fallon RCTs), e.g. fluoxetine often starting 20 mg orally daily with titration and monitoring; sertraline is a pragmatic alternative. Combine with CBT when feasible; joint treatment showed incremental benefit in Fallon’s multi-arm design framework.[2][3]
Collaborative care. Named cardiology/GP medical home; written criteria for re-investigation if new objective red flags; scheduled reviews rather than on-demand angiograms; both–and formulation. Decline non-indicated invasive testing that maintains threat.[1]
Risk. Assess suicide thoroughly — hypochondriasis cohorts show elevated mortality including suicide. Treat depression actively.[6]
Key points
References
- [1]Tyrer P, Cooper S, Salkovskis P, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial Lancet, 2014.PMID 24139977
- [2]Greeven A, van Balkom AJ, Visser S, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial Am J Psychiatry, 2007.PMID 17202549
- [3]Fallon BA, Ahern DK, Pavlicova M, et al. A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis Am J Psychiatry, 2017.PMID 28659038
- [4]Warwick HM, Salkovskis PM Hypochondriasis Behav Res Ther, 1990.PMID 2183757
- [5]Dimsdale JE, Creed F, Escobar J, et al. Somatic symptom disorder: an important change in DSM J Psychosom Res, 2013.PMID 23972410
- [6]Mataix-Cols D, Isomura K, Sidorchuk A, et al. All-Cause and Cause-Specific Mortality Among Individuals With Hypochondriasis JAMA Psychiatry, 2024.PMID 38091000
- [7]Tyrer P, Cooper S, Crawford M, et al. Prevalence of health anxiety problems in medical clinics J Psychosom Res, 2011.PMID 22118381